Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ebola Clinical Trial to Begin Amid Outbreak in DRC
The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.
Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ebola Clinical Trial to Begin Amid Outbreak in DRC

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

clinical research
Nerve Stimulation Gives Paralyzed People Ability to Walk
Nerve Stimulation Gives Paralyzed People Ability to Walk
Abby Olena | Oct 31, 2018
Precisely timed electrical stimulation and intensive rehabilitation restore some capacity to walk among three men more than four years after their debilitating injuries.
Heart Cell Therapy Trial Paused After Fraud Allegations
Heart Cell Therapy Trial Paused After Fraud Allegations
Ashley P. Taylor | Oct 30, 2018
A trial to test whether so-called c-kit cardiac stem cells, first reported by Piero Anversa, could help patients with chronic heart failure has been halted in light of suspicion surrounding his work.
The UK Pharmaceutical Industry Braces for Brexit
The UK Pharmaceutical Industry Braces for Brexit
Diana Kwon | Oct 12, 2018
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Catherine Offord | Sep 18, 2018
Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.
About Half of Clinical Trials Go Unreported in EU
About Half of Clinical Trials Go Unreported in EU
Sukanya Charuchandra | Sep 14, 2018
Pharma companies are more compliant in posting results compared to universities.
Probiotics’ Effects on the Microbiome Vary Widely
Probiotics’ Effects on the Microbiome Vary Widely
Abby Olena | Sep 6, 2018
Experiments in mice and people find that probiotic supplements don’t consistently change the composition of the gut microbiome, and may have adverse effects after antibiotics.
Early Results of First In Vivo Gene-Editing Trial Encouraging
Early Results of First In Vivo Gene-Editing Trial Encouraging
Kerry Grens | Sep 5, 2018
Two patients who received Sangamo’s zinc finger–based treatment for Hunter syndrome have lower biomarkers of the condition, but no signs of new enzyme production.
Adult Cardiac Stem Cells Don’t Exist: Study
Adult Cardiac Stem Cells Don’t Exist: Study
Diana Kwon | Sep 5, 2018
A mouse study adds to the growing body of work disputing the ability of progenitor cells to regenerate muscle tissue in adult mammals’ hearts.